The Center for Science in the Public Interest (CSPI) has submitted a
letter to U.S. Food and Drug Administration (FDA) Commissioner Robert
Califf urging the agency to prohibit retail distribution of highly concentrated
caffeine products, including powdered (PPC), liquid and inhaled
caffeine.

The recently released letter supplements CSPI’s 2014 citizen petition
requesting the ban following the deaths caused by over-ingestion of
caffeine powder. FDA sent warning letters to companies selling the
substance, but “FDA’s five letters appear to have ceased the sale of
powdered caffeine at only the companies to which the agency addressed
the letters,” the CSPI document argues. “In the larger marketplace, sales
of PPC remain commonplace, and the substance is still widely available.
This compelling evidence demonstrates why a ban is the only step that
will protect consumers from the hazards of PPC.”

 

Issue 608

About The Author

For decades, manufacturers, distributors and retailers at every link in the food chain have come to Shook, Hardy & Bacon to partner with a legal team that understands the issues they face in today's evolving food production industry. Shook attorneys work with some of the world's largest food, beverage and agribusiness companies to establish preventative measures, conduct internal audits, develop public relations strategies, and advance tort reform initiatives.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Close